PHARMACY

Lilly names new VP oncology research

BY Allison Cerra

INDIANAPOLIS — Eli Lilly on Thursday announced that it has named Greg Plowman VP oncology research and SVP for ImClone Systems research.

Plowman will oversee the oncology research efforts of both Lilly and ImClone, the drug maker’s subsidiary that it acquired in 2008. He will report to Jan Lundberg, EVP science and technology and Lilly Research Labs president, as well as Bernhard Ehmer, ImClone president.

Prior to accepting the position at Lilly, Plowman served as senior director of research for Genentech for six years. He officially will join the company March 28.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Hospira gets OK to market generic Taxotere

BY Allison Cerra

LAKE FOREST, Ill. — Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

Hospira will offer 20-mg, 80-mg and 160-mg vials of docetaxel at a 10-mg/mL concentration. Docetaxel is a generic version of Sanofi-Aventis’s Taxotere.

Hospira already markets docetaxel in Europe and Australia, the drug maker noted.

"Hospira’s docetaxel will give U.S. cancer patients access to a high-quality, lower-cost alternative to the branded product, [will offer] a differentiated delivery system designed to enhance caregiver safety and [will reinforce] Hospira’s commitment to meet patient and caregiver needs in the oncology space," said Thomas Moore, president, U.S. for Hospira.

U.S. sales of Taxotere were approximately $1.2 billion in 2010, Hospira said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NCPA emphasizes Dispose My Meds program during Patient Safety Awareness Week

BY Allison Cerra

ALEXANDRIA, Va. — In line with Patient Safety Awareness Week, which began Sunday, the National Community Pharmacists Association is encouraging patients to properly dispose of their expired or unused medications safely and effectively.

The NCPA’s Dispose My Meds program, which was developed with Sharps Compliance, gives patients an effective solution to dealing with outdated prescriptions. By logging on to the Dispose My Meds website, consumers can find participating pharmacies by city, state or zip code to dispose of unused medications, excluding controlled substances.

“Pharmacists can help patients monitor what medications are taken, how they interact with other drugs, how effective they are and what side effects they might cause as a way to ensure maximum results,” said Robert Greenwood, NCPA president and pharmacy owner. “During Patient Safety Awareness Week, and anytime, we encourage patients to talk to their community pharmacists about medication safety and how to dispose of medications properly when they go unused or expire.”

To learn more, visit DisposeMyMeds.org.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?